KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomePension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Adient (ADNT) EBITDA (2016 - 2025)

Adient's EBITDA history spans 11 years, with the latest figure at $90.0 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 3.23% year-over-year to $90.0 million, compared with a TTM value of $112.0 million through Dec 2025, down 65.54%, and an annual FY2025 reading of $115.0 million, down 66.47% over the prior year.
  • EBITDA for Q4 2025 was $90.0 million at Adient, down from $120.0 million in the prior quarter.
  • The five-year high for EBITDA was $1.2 billion in Q3 2021, with the low at -$216.0 million in Q1 2025.
  • Average EBITDA over 5 years is $138.7 million, with a median of $103.5 million recorded in 2023.
  • Year-over-year, EBITDA skyrocketed 2240.0% in 2021 and then plummeted 2800.0% in 2025.
  • Tracing ADNT's EBITDA over 5 years: stood at $40.0 million in 2021, then soared by 185.0% to $114.0 million in 2022, then decreased by 2.63% to $111.0 million in 2023, then dropped by 16.22% to $93.0 million in 2024, then fell by 3.23% to $90.0 million in 2025.
  • Per Business Quant, the three most recent readings for ADNT's EBITDA are $90.0 million (Q4 2025), $120.0 million (Q3 2025), and $118.0 million (Q2 2025).